中文 Singapore Government

About Us

Why Singapore

Industry Sectors

Our Services

News Room

Careers


Biomedical Sciences and Healthcare Services

Print Print this page Email Send to a Friend
 
Fast Facts
Singapore's achievements in the Biomedical Sciences (BMS) industry include:
  • Home to six of the world's top 10 pharmaceutical companies' manufacturing facilities

Singapore's distinction in Biomedical Sciences (BMS) and Healthcare Services stems from our unwavering commitment to the advancement of the medical field and our world class facilities solely dedicated to the industry's burgeoning needs.

As one of the key strategic manufacturing sites of the BMS industry, Singapore currently hosts six of the top ten pharmaceutical conglomerates, key industry players and a growing base of medical technology companies within Tuas Biomedical Park, a 183-hectare BMS-dedicated site slated for expansion to double its current capacity due to increasing industry demand.

Singapore also features a dedicated Research & Development complex, the Biopolis, which is home to five biomedical public research institutions and laboratories from the Agency of Science Technology and Research (A*STAR). The Biopolis offers a "plug and play" infrastructure for pharmaceutical and biotechnology companies to share scientific facilities and services, facilitating cross-disciplinary research and public-private collaborations for the advancement of the field and enhancement of your business.

Singapore's status as a nucleus of healthcare service excellence in the region is boosted by the influx of specialist doctors that have enhanced our medical offerings and operational effectiveness, and of international patients seeking our medical expertise.

Click here for Recent Statistics and Case Study Examples.
  Contact Us
 
Contact UsYour Support Network For all your investment needs.
 
  Related Links
 
 
 

Edwards Lifesciences opens new Singapore Heart Valve facility

Over 1000 Business and Scientific Leaders Convene at Biomedical Asia 2008

Sustained Investments in Biomedical Sciences

Perkinelmer expands Global R&D base in Singapore

GlaxoSmithKline opens new research & development pilot plant and increases investment in Singapore to S$1.5 billion

QIAGEN opens New Service Solutions Center in Asia

Pfizer's new facility in Singapore exemplifies its commitment to research and development in Asia

The official opening ceremony of Novartis Singapore Pharma Manufacturing (NSPM)

Schering-Plough Corporation - a key pioneer that has contributed significantly to the growth and development of Singapore's biomedical sciences industry

Schering-Plough - A Distinguished Partner Driving Singapore's Biomedical Sciences Sector